Efficacy and safety of treatments in newly diagnosed adult primary immune thrombocytopenia: a systematic review and network meta-analysisResearch in context
Summary: Background: Immune thrombocytopenia is an autoimmune disease characterised by decreased platelet count. In recent years, novel therapeutic regimens have been investigated in randomised controlled trials (RCTs). We aimed to compare the efficacy and safety of different treatments in newly di...
Main Authors: | Yun Wang, Lei Sheng, Fengjiao Han, Qiuyu Guo, Zihan Zhang, Yu Hou, Qi Feng, Hai Zhou, Xuebin Ji, Jun Peng, Ming Hou, Miao Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-02-01
|
Series: | EClinicalMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537022005065 |
Similar Items
-
Efficacy of Dexamethasone for Acute Primary Immune Thrombocytopenia Compared to Prednisolone: A Systematic Review and Meta-analysis
by: Yasuyuki Arai, et al.
Published: (2017-07-01) -
Rituximab Therapy for Refractory Autoimmune Thrombocytopenia in Systemic Lupus Erythematosus
by: Didem Atay, et al.
Published: (2012-03-01) -
Steroid-resistant autoimmune thrombocytopenia in systemic lupus erythematosus treated with rituximab
by: Vasudha V Sardesai, et al.
Published: (2015-01-01) -
The efficacy and safety of low-dose rituximab in immune thrombocytopenia: a systematic review and meta-analysis
by: Yunjie Li, et al.
Published: (2019-08-01) -
Anti-GPIb/IX autoantibodies are associated with poor response to dexamethasone combined with rituximab therapy in primary immune thrombocytopenia patients
by: Bingjie Ding, et al.
Published: (2023-12-01)